Skip to main content
. 2023 Nov 27;8(49):46922–46933. doi: 10.1021/acsomega.3c06700

Table 1. Percentage of Cell Growth Inhibition of the Tested Compounds against MCF-7 and HepG2 Lines Using the MTT Assay.

code % of cell inhibition ± SD at [100 μM]
  MCF7 HepG2
2 41.92 ± 1.9 43.49 ± 1.8
3 55.07 ± 2.1 57.79 ± 1.9
4 72.13 ± 2.9 75.85 ± 2.3
5 46.96 ± 1.4 68.98 ± 2.1
6 78.25 ± 2.2 79.25 ± 2.2
8 59.75 ± 1.7 57.84 ± 1.6
11 78.59 ± 2.3 68.77 ± 1.6
12 84.20 ± 2.6 85.13 ± 2.1
13 64.56 ± 1.8 56.36 ± 1.4
14 48.76 ± 1.2 35.55 ± 1.1
doxorubicin 90.20 ± 2.1 79.13 ± 2.3